Bonraybio Co., Ltd. (TPE:6955)
Taiwan · Delayed Price · Currency is TWD 162.00
+2.50 (1.57%)
At close: Jan 21, 2026
Bonraybio Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 287.1 | 222.88 | 159.64 | 106.27 | 56.3 | 26.59 | |
Revenue Growth (YoY) | 36.00% | 39.61% | 50.22% | 88.78% | 111.72% | - |
Cost of Revenue | 62.82 | 47.92 | 39.85 | 25.68 | 16.72 | 5.04 |
Gross Profit | 224.28 | 174.96 | 119.79 | 80.59 | 39.58 | 21.55 |
Selling, General & Admin | 80.76 | 72.24 | 57.34 | 47.72 | 34.24 | 31.43 |
Research & Development | 49.66 | 41.76 | 41.12 | 39.51 | 43.84 | 39.27 |
Operating Expenses | 130.42 | 114.01 | 98.45 | 87.23 | 78.08 | 70.7 |
Operating Income | 93.86 | 60.95 | 21.34 | -6.64 | -38.5 | -49.15 |
Interest Expense | -0.18 | -0.18 | -0.22 | -0.15 | -0.21 | -0.23 |
Interest & Investment Income | 6.07 | 3.95 | 3.01 | 1.46 | 0.58 | 0.62 |
Currency Exchange Gain (Loss) | -2.02 | 3.54 | 0.16 | - | -0.68 | -0.19 |
Other Non Operating Income (Expenses) | 0.31 | 0.12 | 0.96 | 7.05 | 7.54 | 8.2 |
EBT Excluding Unusual Items | 98.04 | 68.39 | 25.25 | 1.71 | -31.27 | -40.75 |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.42 | -0.42 |
Other Unusual Items | - | - | 0.5 | - | - | - |
Pretax Income | 98.04 | 68.39 | 25.75 | 1.71 | -31.69 | -41.17 |
Income Tax Expense | 1.76 | 0.03 | 0.03 | 0.02 | 0.02 | -0.01 |
Net Income | 96.28 | 68.37 | 25.73 | 1.69 | -31.71 | -41.16 |
Net Income to Common | 96.28 | 68.37 | 25.73 | 1.69 | -31.71 | -41.16 |
Net Income Growth | 73.96% | 165.75% | 1423.09% | - | - | - |
Shares Outstanding (Basic) | 24 | 23 | 23 | 20 | 16 | 14 |
Shares Outstanding (Diluted) | 24 | 23 | 23 | 20 | 16 | 14 |
Shares Change (YoY) | 8.11% | 0.83% | 11.52% | 27.51% | 16.91% | - |
EPS (Basic) | 3.94 | 3.00 | 1.14 | 0.08 | -1.99 | -3.02 |
EPS (Diluted) | 3.92 | 2.99 | 1.14 | 0.08 | -1.99 | -3.02 |
EPS Growth | 60.16% | 162.75% | 1268.34% | - | - | - |
Free Cash Flow | 77.95 | 77.96 | 21.26 | 7.9 | -28.05 | -24.92 |
Free Cash Flow Per Share | 3.18 | 3.42 | 0.94 | 0.39 | -1.76 | -1.83 |
Dividend Per Share | 1.304 | 1.304 | 0.151 | - | - | - |
Dividend Growth | 762.63% | 762.63% | - | - | - | - |
Gross Margin | 78.12% | 78.50% | 75.04% | 75.83% | 70.30% | 81.04% |
Operating Margin | 32.69% | 27.35% | 13.37% | -6.25% | -68.39% | -184.85% |
Profit Margin | 33.54% | 30.67% | 16.11% | 1.59% | -56.34% | -154.79% |
Free Cash Flow Margin | 27.15% | 34.98% | 13.32% | 7.43% | -49.83% | -93.71% |
EBITDA | 102.32 | 68.84 | 28.72 | 2.87 | -30.15 | -39.73 |
EBITDA Margin | 35.64% | 30.89% | 17.99% | 2.70% | -53.56% | -149.43% |
D&A For EBITDA | 8.46 | 7.88 | 7.38 | 9.51 | 8.35 | 9.42 |
EBIT | 93.86 | 60.95 | 21.34 | -6.64 | -38.5 | -49.15 |
EBIT Margin | 32.69% | 27.35% | 13.37% | -6.25% | -68.39% | -184.85% |
Effective Tax Rate | 1.80% | 0.04% | 0.10% | 1.40% | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.